abrdn Life Sciences Investors (HQL) income statement
HQLNYSEFiscal year ends September 30
$17.49−0.13 (-0.74%)
Close on Nov 18, 2026Market cap –P/E –Yield –
abrdn Life Sciences Investors income statement
Ratios
Latest available
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY
- –
Financial strength
- Current ratio
- –
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- –
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?